Stanley P. Kolis

RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Hong Yang, Brian Higgins, Kenneth Kolinsky et al. · Cancer Research · 2010 · 405 citations

Medicine, Oncology, Pharmacology +16

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles

Thomas A. Engler, Kelly Furness, Sushant Malhotra et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Process Safety in the Pharmaceutical Industry—Part I: Thermal and Reaction Hazard Evaluation Processes and Techniques

Ayman D. Allian, Nisha P. Shah, Antonio C. Ferretti et al. · Organic Process Research & Development · 2020 · 53 citations · Full text

Engineering, Chemical Engineering, Pharmaceutical Manufacturing +16

(<i>S</i>)-<i>N</i>-{3-[1-Cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1<i>H</i>-indol-7-yl}-methanesulfonamide: A Potent, Nonsteroidal, Functional Antagonist of the Mineralocorticoid Receptor

Michael G. Bell, Douglas L. Gernert, Timothy A. Grese et al. · Journal of Medicinal Chemistry · 2007 · 47 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis of Aryl- and Heteroaryl[<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazoles

Concha Sánchez-Martı́nez, Margaret M. Faul, Chuan Shih et al. · The Journal of Organic Chemistry · 2003 · 46 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15